and actually SARS-CoV-2 causing COVID-19, all are characterized by persistent inflammation, continuous production of reactive oxygen/nitrogen species and oxidative stress that predominate over the antioxidant defenses (GSH and free radical scavenger enzymes) resulting in cell/tissue/organ aging associated with early (premature) chronic inflammation/inflammaging. We propose that, although inflammaging was introduced for the aging process (276289), it could also apply to early (premature) tissue and organ aging associated with cell and tissue damage caused by excessive oxidative stress and lack of adequate antioxidant defenses, especially low GSH levels, in younger individuals
After some initial reflections from various editors of planning journals, we will open the roundtable for comments and questions from the audience
(NASDAQ: AMGN) is ranked tenth in this report on the basis of its growing overall pharmaceutical scale and, most significantly, its uniquely differentiated MariTide a peptide-antibody conjugate that is the most scientifically interesting GLP-1-adjacent molecule in late-stage development
Prevent cardiac events Recent studies have shown that the MOTS-c peptide may protect against cardiac dysfunction Reference: Who Should Consider MOTS-c Peptide Therapy
Structure Therapeutics announces initiation of phase 1 clinical study of oral small molecule amylin receptor agonist ACCG-2671 for the treatment of obesity
